68 related articles for article (PubMed ID: 7742775)
1. Colchicine-resistance and enhancement of P-glycoprotein activity after co-cultivation of drug-sensitive cells with multidrug resistant variants.
Eliseenkova AV; Kakpakova ES; Abdrjashitov RI; Stavrovskaya AA
Cell Biol Int; 1995 Feb; 19(2):113-9. PubMed ID: 7742775
[TBL] [Abstract][Full Text] [Related]
2. Induction of P-glycoprotein functional activity and multidrug resistance by a soluble factor(s) produced by some mammalian cells.
Eliseenkova AV; Ktitorova OV; Kakpakova ES; Sidorova TA; Stavrovskaya AA
Membr Cell Biol; 1998; 12(4):469-79. PubMed ID: 10367565
[TBL] [Abstract][Full Text] [Related]
3. Amine oxidase, spermine, and hyperthermia induce cytotoxicity in P-glycoprotein overexpressing multidrug resistant Chinese hamster ovary cells.
Lord-Fontaine S; Agostinelli E; Przybytkowski E; Averill-Bates DA
Biochem Cell Biol; 2001; 79(2):165-75. PubMed ID: 11310564
[TBL] [Abstract][Full Text] [Related]
4. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle-dependent turnover of P-glycoprotein in multidrug-resistant cells.
Zhang W; Ling V
J Cell Physiol; 2000 Jul; 184(1):17-26. PubMed ID: 10825230
[TBL] [Abstract][Full Text] [Related]
6. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
7. Gain and loss of hypersensitivity to resistance modifiers in multidrug resistant Chinese hamster ovary cells.
Warr JR; Quinn D; Elend M; Fenton JA
Cancer Lett; 1995 Nov; 98(1):115-20. PubMed ID: 8529199
[TBL] [Abstract][Full Text] [Related]
8. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
9. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
Nare B; Prichard RK; Georges E
Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
11. Stable transfection of the P-glycoprotein promoter reproduces the endogenous overexpression phenotype: the role of MED-1.
Ince TA; Scotto KW
Cancer Res; 1996 May; 56(9):2021-4. PubMed ID: 8616844
[TBL] [Abstract][Full Text] [Related]
12. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein is overexpressed and functional in severely heat-shocked hepatoma cells.
Hevér-Szabó A; Pirity M; Szathmári M; Venetianer A
Anticancer Res; 1998; 18(4C):3045-8. PubMed ID: 9713507
[TBL] [Abstract][Full Text] [Related]
14. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
15. Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism distinct from multidrug resistance.
Cao C; Steinberg TH; Neu HC; Cohen D; Horwitz SB; Hickman S; Silverstein SC
Infect Agents Dis; 1993 Aug; 2(4):193-200. PubMed ID: 7909709
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
Yang JM; Goldenberg S; Gottesman MM; Hait WN
Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
[TBL] [Abstract][Full Text] [Related]
17. Relationship between multidrug resistance, hypersensitivity to resistance modifiers and cell volume in Chinese hamster ovary cells.
Vickers SE; Stow MW; Warr JR
Cell Biol Int; 1993 May; 17(5):477-85. PubMed ID: 8101756
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
19. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein.
Barancík M; Bohácová V; Zbýnovcová M; Breier A
Gen Physiol Biophys; 1999 Mar; 18(1):45-56. PubMed ID: 10378120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
